Collegium Pharmaceutical
(NASDAQ) COLL
Collegium Pharmaceutical Financials at a Glance
Market Cap
$988.58M
Revenue (TTM)
$796.33M
Net Income (TTM)
$74.95M
EPS (TTM)
$2.04
P/E Ratio
14.92
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$31.10
Volume
474,330
Open
$30.48
Price
$31.10
Volume
474,330
Open
$30.48
Previous Close
$31.06
Daily Range
$30.13 - $31.24
52-Week Range
$29.08 - $50.79
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$31.10
Volume
474,330
Open
$30.48
Previous Close
$31.06
Daily Range
$30.13 - $31.24
52-Week Range
$29.08 - $50.79
COLL News
COLL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Collegium Pharmaceutical
Industry
Pharmaceuticals
Sector
Health CareEmployees
423
CEO
Vikram Karnani, MBA
Website
www.collegiumpharma.comHeadquarters
Stoughton, MA 02072, US
COLL Financials
Key Financial Metrics (TTM)
Gross Margin
61%
Operating Margin
24%
Net Income Margin
9%
Return on Equity
27%
Return on Capital
16%
Return on Assets
5%
Earnings Yield
6.70%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$988.58M
Shares Outstanding
32.43M
Volume
474.33K
Avg. Volume
534.52K
Financials (TTM)
Gross Profit
$463.26M
Operating Income
$187.08M
EBITDA
$401.01M
Operating Cash Flow
$329.32M
Capital Expenditure
-$1.74M
Free Cash Flow
$327.58M
Cash & ST Invst.
$406.53M
Total Debt
$940.56M
Collegium Pharmaceutical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$193.52M
+8.9%
Gross Profit
$117.25M
+20.5%
Gross Margin
60.59%
N/A
Market Cap
$988.58M
N/A
Market Cap/Employee
$2.77M
N/A
Employees
357
N/A
Net Income
$14.50M
+499.8%
EBITDA
$87.90M
+9.2%
Quarterly Fundamentals
Net Cash
-$386.30M
+40.2%
Accounts Receivable
$228.76M
+0.0%
Inventory
$42.74M
+14.8%
Long Term Debt
$777.77M
-0.1%
Short Term Debt
$34.07M
-48.3%
Return on Assets
4.54%
N/A
Return on Invested Capital
15.61%
N/A
Free Cash Flow
$56.84M
+4.1%
Operating Cash Flow
$57.11M
+3.1%